Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...
lupus nephritis
Better Lupus Care Reducing Deaths from Lupus Nephritis, Study Shows
April 22, 2019
Results of a study published in Arthritis & Rheumatology shows that end-stage renal disease and mortality due...
Patients with Lupus Nephritis-Related Kidney Disease Are Living Longer
March 28, 2019
A new study published this March in Arthritis & Rheumatology found that deaths among patients with end-stage...
Study Finds Mycophenolate Mofetil Comparable to Standard Treatment for Pediatric Lupus Nephritis
March 19, 2019
A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...
New Approach to Treating Lupus Nephritis
February 6, 2019
Scientists partly funded by the Lupus Research Alliance have found a potential new way to protect the...
Protein Osteopontin Indicator of Lupus Nephritis, Shows Clinical Trial
February 1, 2019
Raised levels of a protein osteopontin were shown to indicate lupus nephritis and higher disease activity, in...
Study Shows Kidney Transplant Improves Lupus Nephritis Survival
January 21, 2019
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus...
2018 Distinguished Innovator Awardees Named by Lupus Research Alliance
NEW YORK, NY. December 20. The Lupus Research Alliance is proud to announce the 2018 recipients of the Dr. William...
Looking at Iron as a Trigger for Lupus Nephritis
As the provider of life-giving oxygen to organ systems through its role in red blood cell production — the...
Good News from Aurinia Pharmaceuticals for Lupus Nephritis
September 25, 2018
Congratulations to Aurinia Pharmaceuticals for completing patient enrollment in the AURORA Phase 3 clinical trial ahead of...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...